Verify Diagnostics Rapid Coronavirus Antibody Test Gets Canadian Authorization

Feb 17, 2021

|

NEW YORK — Verify Diagnostics said on Tuesday that it has received authorization from Canadian regulators for its Assure Tech Ecotest COVID-19 serological rapid test for SARS-CoV-2 infection.

According to the Ontario-based company, the point-of-care test is designed to detect antibodies against SARS-CoV-2 in a fingerstick blood sample.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Verify Diagnostics Rapid Coronavirus Antibody Test Gets Canadian Authorization

To read the full story....

Breaking News

Quanterix Q4 Revenues Up 64 Percent

Oppenheimer Initiates Coverage of MDxHealth at Outperform

RenalytixAI Reports Q2 2021 Revenues of $400K

Guardant360 CDx Receives CE Mark for Tumor Mutational Profiling and Tagrisso CDx Use

Aegea, Biocept Ink Supply Agreement for Coronavirus MDx Test

Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

Featured White Papers

Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind

Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs

What's Popular?

Quidel At-Home, Rapid Antigen, COVID-19 Test Gets FDA Emergency Use Authorization

Hologic Acquires European MDx Firm Diagenode for Approximately $159M

Reference Labs Take Diverse Approaches to Mitigating COVID-19 Sample Shipping Delays

LightDeck Sketches Commercial Plans for Five-Minute Multiplex Tests For SARS-CoV-2, Other Conditions

FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

Sponsorships